Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™
Nurses - 0.25 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)
Pharmacists - 0.25 Knowledge-based ACPE (0.025 CEUs)
Physician Assistant - 0.25 AAPA hour(s) of Category I credit
IPCE - 0.25 Interprofessional Continuing Education (IPCE) credit
This activity is intended for obstetricians/gynecologists/women’s health clinicians, cardiologists, diabetologists/endocrinologists, family medicine/primary care clinicians, nurses, pharmacists, physician assistants, and other members of the health care team for pregnant women.
The goal of this activity is for learners to be better able to describe the associations of concordance to a Mediterranean diet pattern around the time of conception with lower risk of developing any adverse pregnancy outcome and individual adverse pregnancy outcomes.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.
Medscape designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number: JA0007105-0000-23-059-H01-P).
Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until 02/17/2024. PAs should only claim credit commensurate with the extent of their participation.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / CE Released: 2/17/2023
Valid for credit through: 2/17/2024
processing....
The Centers for Disease Control and Prevention reports that US pregnancy-related mortality has increased steadily during the past 30 years, with significant racial and age disparities. Adverse pregnancy outcome (APOs) are leading risk factors for maternal morbidity/mortality, mandating APO prevention.
Poor diet quality is common among US women periconceptionally, and dietary patterns seldom change significantly from prepregnancy to early pregnancy. Periconceptual diet is therefore an important potential target for reducing APOs. Mediterranean diet has been linked to health and longevity and might help prevent APOs.
Women in the United States who followed a Mediterranean-style diet (heavy on fresh foods, fish, and olive oil) around the time of conception had lower risk of developing a pregnancy complication, results of a large new study suggest.
The study included 7,798 women who had not given birth before. The group was geographically, racially, and ethnically diverse.
Researchers led by Nour Makarem, PhD, from the Department of Epidemiology, Columbia University, New York, published their results in JAMA Network Open.
“Generally higher intakes of vegetables, fruits, legumes, fish, and whole grains and lower intakes of red and processed meat were associated with lower risk of APOs,” the authors write.
21% Lower Risk for ComplicationsThe investigators found that women in the study, who were part of the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be, which enrolled 10,038 women between October 1, 2010, and September 30, 2013, and scored high on adherence to a Mediterranean diet, had a 21% lower risk of developing any APO than those who had low adherence. And the better the adherence, the lower the risk for adverse outcomes, especially preeclampsia or eclampsia and gestational diabetes, the researchers write.
The research team also studied how following the diet correlated with gestational high blood pressure, preterm birth, delivery of a small-for-gestational-age infant, and stillbirth.
Women were scored on consumption of 9 components: vegetables (excluding potatoes), fruits, nuts, whole grains, legumes, fish, monounsaturated to saturated fat ratio, red and processed meats, and alcohol.
No Differences By Race, Ethnicity, or Body Mass IndexThere were no differences in adverse pregnancy outcomes by race, ethnicity, or the woman’s body mass index before pregnancy, but associations were stronger in the women who were aged 35 years or older, according to the article.
The authors point out that the women in the study had access to prenatal care at a large academic medical center during their first 3 months of pregnancy, so the study may actually underestimate the importance of the diet in the pregnancy outcomes.
Christina Han, MD, division director of maternal-fetal medicine at University of California, Los Angeles, who was not part of the study, said that the results make sense, as the researchers looked at the time of conception, which is a time that reflects the way a person chooses to live their life.
“We know that your health state as you enter pregnancy can significantly affect your outcomes for that pregnancy,” she said. “We’ve known for decades now that a Mediterranean diet is good for just about everybody.”
Unequal Access to Foods on DietDr Han said that although it is great that the researchers were able to confirm the benefit of the Mediterranean diet, it highlights inequity, as lower-income people are not as likely to be able to afford fresh fruits and vegetables and fish.
“This is a call to arms for our food distribution system to even out the big divide in what patients have access to,” Dr Han said.
She noted that most of the women in this study were married, non-Hispanic White, and had higher levels of education, which may make it hard to generalize these results to the general population.
A limitation of the study is that the women were asked to report what they ate themselves, which can be less accurate than when researchers record what is eaten in a controlled setting.
The researchers suggested a next step: “Long-term intervention studies are needed to assess whether promoting a Mediterranean-style diet pattern around the time of conception and throughout pregnancy can prevent APOs.”
Dr Makarem reported receiving grants from the National Institutes of Health and the American Heart Association outside the submitted work. One coauthor reported receiving grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development during the study. One coauthor reported receiving personal fees for serving on the board of directors for iRhythm and from fees paid through Cedars-Sinai Medical Center from Abbott Diagnostics and Sanofi outside the submitted work, and a coauthor reported serving as a clinical end point committee member for GlaxoSmithKline outside the submitted work. No other disclosures were reported. Dr Han has disclosed no relevant financial relationships.
JAMA Netw Open. 2022;5(12):e2248165.[1]